All articles by Linda Stewart – Page 9
-
NewsStudy shows Mpox (monkeypox) antibodies wane within a year of vaccination
New research shows that the antibodies produced by Modified Vaccinia virus Ankara - Bavarian Nordic (MVA-BN) vaccination against mpox wane significantly within a year of receiving the vaccination.
-
NewsSignificant decline of neutralising antibodies to monkeypox virus during the first month after vaccination
New research shows that even in men who receive two doses of mpox vaccine intradermally, their level of antibodies to the virus falls to low or zero within the first few months if they have not received a previous smallpox vaccine.
-
NewsScientists have a new tool in the race to improve the diagnosis and prognosis of sepsis
Scientists identify unique molecular signatures of sepsis and use AI to improve diagnosis and identify patients most likely to develop severe symptoms and suffer poor outcomes.
-
NewsProbiotics in kombucha mimic fasting and reduce fat stores in worms
In a new study, researchers found that the microbes in kombucha tea make changes to fat metabolism in the intestines of a model worm species that are similar to the effects of fasting.
-
NewsTB vaccine may enable elimination of the disease in cattle by reducing its spread
Vaccination not only reduces the severity of TB in infected cattle, but reduces its spread in dairy herds by 89%, research finds.
-
NewsWild nematode worms learn to avoid harmful bacteria—and their offspring inherit this knowledge
The nematode worm C. elegans will stay away from dangerous bacteria in its environment when exposed to certain bacterial RNAs—and can transmit that learned behavior to future generations.
-
NewsA combination of approved drugs enhances the delivery of anti-bacterial medications to treat tuberculosis
Scientists repurposed approved drugs that they originally tested to normalize blood vessels surrounding tumors to improve drug delivery to cancer cells.
-
NewsScientists develop an innovative compound effective against malaria and leishmaniasis
Initially designed for malaria, this drug shows high efficacy against leishmaniasis, representing a unique and promising breakthrough for the treatment of both infections.
-
NewsDangerous surgical site infections can be reduced with simple prevention protocol
A new study demonstrates the use of a simple pre-surgical infection prevention protocol to prevent dangerous post-surgical infections.
-
NewsMore older adults being diagnosed with STIs such as gonorrhoea and syphilis
STIs in Americans aged 55 to 64 years have more than doubled over the past decade; in England the number of over 45s diagnosed with gonorrhoea and syphilis doubled between 2015 and 2019.
-
NewsNominations open for Applied Microbiology International Awards 2024
Applied Microbiology International is delighted to announce that its acclaimed awards programme is now open for nominations.
-
NewsNew enzymatic cocktail can kill tuberculosis-causing mycobacteria
A new study shows that an enzymatic cocktail can kill a variety of mycobacterial species of bacteria, including those that cause tuberculosis.
-
NewsSilicon spikes skewer 96% of virus particles
An international research team has designed and manufactured a virus-killing surface that could help control disease spread in hospitals, labs and other high-risk environments.
-
NewsResearchers identify microbes that help plants thwart parasite
Researchers have shown that soil microbes induce changes in sorghum roots that make the plant more resistant to infection by witchweed. They identified specific strains of bacteria that trigger these resistance traits and could be applied as a soil ’probiotic’.
-
NewsOral bacteria accelerate pancreatic cancer development in mice: research reveals key findings
A new study unveils a significant connection between oral bacteria and pancreatic cancer development in mice and sheds light on a previously recognized link between oral health and pancreatic cancer, one of the deadliest forms of cancer.
-
NewsImplantable device delivers HIV antiviral with more potency than oral drugs
A study shows that a nanofluidic implant delivered an HIV drug that achieved more potency than other forms of drug administration (oral) and other HIV drugs.
-
NewsNew testing approach improves detection of rare but emerging Powassan virus spread by deer ticks
Researchers have come up with a new, more accurate method for detecting in ticks the emerging Powassan virus, which can cause life-threatening neuroinvasive disease, including encephalitis and meningitis.
-
NewsEpstein-Barr virus hijacks host genome boosting nasopharyngeal carcinoma
Researchers unravel the mechanisms of Epstein-Barr virus (EBV) and host chromatin interactions in nasopharyngeal cancer cells.
-
NewsResearchers a step closer to a cure for HIV
A new study demonstrates that a patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective than other candidate HIV cure therapeutics for people living with chronic HIV on combined antiretroviral therapy (cART).
-
NewsSniffing out bacteria: a novel approach for rapid bacterial species identification
Researchers have used proton transfer reaction-mass spectrometry (PTR-MS) and fast gas chromatography-proton transfer reaction-mass spectrometry (FGC-PTR-MS) to detect volatile organic compounds (VOCs) emitted by six types of bacteria.
